The Latest Breaking News from FDA

LOS ANGELES -- Patients arriving at Dr. Philip O'Carroll's Newport Beach office for their first ketamine treatment are in pain and often lost. They have visited other doctors, tried other solutions and are ready for what is considered a last resort.

Obstetricians, gynecologists, other medical professionals, and abortion rights advocates petitioned the U.S. Food and Drug Administration (FDA) on Tuesday to urge Danco Laboratories to seek approval of mifepristone, a pill used in terminating early pregnancies at home, for miscarriage management.

‘I’m happy, healthy, and more importantly, extremely lucky to be able to get back to my normal self’

Myovant Sciences turned down a takeover bid from majority shareholder Sumitovant Biopharma on Monday, and MYOV stock skyrocketed.

Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he’s not sure it helps.

No deaths have been linked to listeria cases

Nearly half of US infant formula contain corn sugars. Mounting evidence suggests it may not be the best for babies

A controversial new drug for ALS could add months to patients' lives – if it actually works

The Fed’s aggressive monetary policies are raising recession fears. Amid such an environment, we think investors could consider adding AbbVie (ABBV), Pfizer (PFE), and Coca-Cola (KO) to their portfolios for stable returns. Read on to learn more….